Personalizing Microinvasive Glaucoma Surgery in a Complex Treatment Landscape

This session, which was included as part of the 2023 Ophthalmology 360 Summit Series, will provide an overview of currently available microinvasive glaucoma surgery (MIGS) procedures, including their safety and efficacy and strategies for identifying appropriate candidates and personalizing treatment selection. It will also review strategies for improving the co-management of patients who are candidates for MIGS or have undergone these procedures.

Upon completion of the educational activity, participants should be able to:

• Describe the clinical safety and efficacy associated with currently available MIGS approaches and devices
• Identify MIGS candidates and personalize treatment selection
• Implement strategies to improve the co-management of patients who are candidates for or have undergone MIGS

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at ketrea@akhcme.com